What Happened?
Shares of healthcare company Baxter International (NYSE: BAX) jumped 3.6% in the afternoon session after TD Cowen raised its price target on the stock to $24 from $20. The firm maintained its hold rating on the shares, which suggests the analyst recommends neither buying nor selling the stock at its current price. However, the increased price target indicates a more positive valuation outlook for the company than before. The move from the investment firm comes as Baxter holds an average rating of hold among analysts, with a mean price target of $20.44.
The shares closed the day at $23.34, up 4.2% from the previous close.
Is now the time to buy Baxter? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Baxter’s shares are somewhat volatile and have had 11 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 12 months ago when the stock dropped 20% on the news that the company reported disappointing second-quarter results and cut its full-year profit forecast, citing the lingering impact of a hurricane.
The healthcare company pointed to the lingering effects of Hurricane Helene, which damaged a key manufacturing facility and disrupted the supply of its IV solutions. Baxter’s adjusted earnings per share of 59 cents missed analysts' estimates, while revenue of $2.81 billion also came in slightly below expectations. In response to these challenges and what management called demand softness, the company lowered its full-year profit guidance. The weak results and revised outlook prompted a negative reaction from investors.
Baxter is up 19.8% since the beginning of the year, but at $23.37 per share, it is still trading 19% below its 52-week high of $28.84 from July 2025. Despite the year-to-date gain, investors who bought $1,000 worth of Baxter’s shares 5 years ago would now be looking at only $284.61.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
